공지 • May 05
Iofina plc, Annual General Meeting, Jun 09, 2026 Iofina plc, Annual General Meeting, Jun 09, 2026. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom 공지 • Apr 16
Iofina plc Provides Production Guidance for the First Half of Fiscal Year 2026 Iofina plc provided production guidance for the first half of fiscal year 2026. For the period, The Company now expects to exceed the previous H1 2026 production guidance of 325MT-355MT. Based on the current trends, the Company is now anticipating H1 2026 production to be closer to 385MT. 공지 • Jan 13
Iofina plc Provides Earnings Guidance for 2025 and Production Guidance for the First Half of 2026 Iofina plc provided earnings guidance for 2025 and production guidance for the first half of 2026. For the 2025, the company's revenue are projected to surpass $65 million.
For the first half of 2026, the company expects to produce between 325 MT-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT). 공지 • Dec 14
Iofina plc Announces the Proposed Appointment of Tim Hughes as a Non-Executive Director, Effective 1 January 2026 Iofina plc announced the proposed appointment of Tim Hughes as a Non-Executive Director, to take effect from 1 January 2026. Tim has significant experience in general management in the specialty chemical industry as well as corporate and sustainability matters. Tim was a member of the Executive Committee of Synthomer plc for 11 years until 2023 as divisional director for the industrial specialties global business, which included the company's specialty iodine business, before then becoming President of Corporate Development, where he was responsible for investor relations, external affairs and the development of the company's sustainability strategy. Prior to Synthomer, Tim led the Urethane Technologies joint venture business for Chemtura Corporation and spent 14 years in business leadership and marketing roles at Courtaulds plc. Tim is based in the UK and holds a BSc in Chemistry from the University of Manchester and an MBA from Cranfield University. Concurrent with his appointment, Tim will also be appointed as a member of Iofina's Audit and Remuneration Committees. Timothy John Hughes, age 61, is currently or has been a Director of the following companies within the past five years: Current Directorships at Catalyst Science Discovery Centre and Museum Trust Limited, Synthomer (UK) Limited and Chemical Industries Association Limited and Previous Directorships at Synthomer (UK) Limited. 공지 • Oct 17
Iofina plc Provides Production Guidance for the Second Half of 2025 Iofina plc provided production guidance for the second half of 2025. For the period, the company expects production is on track to be within the production range of 400 MT - 440 MT. 공지 • May 15
Iofina plc, Annual General Meeting, Jun 09, 2025 Iofina plc, Annual General Meeting, Jun 09, 2025. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom 공지 • Apr 19
Iofina plc Revises Production Guidance for First Half of 2025 Iofina plc revised production guidance for first half of 2025. For the period, the company now expects total iodine production for first half of 2025 to be closer to 300MT compared to the previously guided range of 320MT-355MT. The company will provide a further update on Iofina Resources' production as part of its year-end 2024 financial reporting. 공지 • Jul 16
Iofina plc Provides Production Guidance for the Second Half of 2024 Iofina plc provided production guidance for the second half of 2024. The company anticipates production in the second half of 2024 to be in the range of 355 MT - 380 MT. 공지 • May 17
Iofina plc, Annual General Meeting, Jun 13, 2024 Iofina plc, Annual General Meeting, Jun 13, 2024. Location: the offices of canaccord genuity, 88 wood street, ec2v 7qr, london United Kingdom 공지 • May 16
Iofina plc Announces Resignation of William ("Bill") D. Bellamy as Director Iofina plc announced that Dr. William ("Bill") D. Bellamy, Chair of the Remuneration Committee, will retire as a Director of the Company at the close of the AGM and is therefore not being submitted for re-appointment in the business of the meeting. 공지 • Jan 15
Iofina plc Provides Market Update Regarding Its Activities During Fourth Quarter 2023 and Outlines Expectations for 2024 Iofina plc provided a market update regarding its activities during Fourth Quarter 2023 and outlines expectations for 2024. With IO#9 plant operating at an improved production rate in the second half of Fourth Quarter 2023,crystalline iodine production across Iofina Resources' six plants for the last quarter increased year over year by 16% to 160.9 metric tonnes (MT). Total production during the second half was 317.8MT, which aligned with the Company's guidance that H2 2023 production would either be at the bottom or very marginally below the forecast range of 325-350MT. This nevertheless represents a13% increase over production of 282.0MT for H2 2022. Total crystalline iodine production in 2023 was up 8% to 559.3MT, compared to 2022 production levels of 516MT. The iodine spot price softened by circa five percent over H2 2023 towards mid-to-upper sixties dollars per kilogram as prices have settled from historically high levels. Moving into 2024, the market fundamentals of the iodine business remain strong and Iofina currently expects the spot price to remain at present levels for the foreseeable future. Demand for the Company's crystalline iodine remained robust during the final quarter, whilst sales of iodine derivatives had mixed results. Regarding non-iodine products, sales of a key product mainly used in the semiconductor industry improved significantly in the second half of the year after a slower-than-anticipated first half. Moving into 2024, Iofina Resources expects to produce 275MT - 295MT of crystalline iodine during the first half (H1 2023: 242MT), which would result in a 13% to 22% increase over H1 2023. The Company reiterates that H1 iodine plant production has historically always been lower than H2 production due to the effect of lower temperatures on production in the winter months, whereas H2 production benefits from greater output in the warmer summer period. Encouraging progress has also been made regarding construction plans for IO#10 plant, with groundwork at the site scheduled to commence this week. The Company expects IO#10 iodine production to commence in Third Quarter 2024 and will update on progress as appropriate. Negotiations continue to progress well with both current and potential new brine supply partners for IO#11, and the Company continues to explore options in its current core area and other new areas for next iodine production facilities. In terms of new products, Iofina Chemical will beadding to its iodine derivatives product range in H1 2024, including an existing product in the market for which there is strong demand. The Company also expects to increase sales of its crystalline iodine to customers in Europe in 2024 through existing and new relationships. The Group is committed to operating its facilities with a safety-first approach and is proud to report that Iofina has had no lost time incidents since April 2021. 공지 • Oct 20
Iofina plc Provides Production Guidance for the Second Half of 2023 Iofina plc provided production guidance for the second half of 2023. the company expected second half production is trending towards the lower end of company's forecast of 325-350 MT. 공지 • Sep 12
Iofina plc Provides Production Guidance for the Second Half of 2023 Iofina plc provided production guidance for the second half of 2023. With the addition of IO#9 output, second half 2023 production is on track to meet the 325-350MT target. 공지 • May 09
Iofina plc, Annual General Meeting, Jun 14, 2023 Iofina plc, Annual General Meeting, Jun 14, 2023, at 09:00 Coordinated Universal Time. Location: Canaccord Genuity, 88 Wood Street London United Kingdom Agenda: To receive and adopt the reports of the directors and the auditors and the audited financial statements of the Company for the year ended 31 December 2022; to re-appoint Malcolm Lewin as director; to re-appoint Mary Fallin Christensen as a director; to re-appoint UHY Hacker Young LLP as the Company's auditors to hold office from the conclusion of the AGM to the conclusion of the next meeting at which the accounts are laid before the Company and to authorise the directors to determine remuneration. 
